Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study.

[1]  N. Litviakov,et al.  Human papillomavirus and lung cancer: an overview and a meta-analysis , 2019, Journal of Cancer Research and Clinical Oncology.

[2]  C. Page,et al.  Head and neck squamous cell carcinoma and metachronous second primaries. , 2019, European annals of otorhinolaryngology, head and neck diseases.

[3]  E. Dronkers,et al.  Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable , 2019, Head & neck.

[4]  J. Pavie,et al.  [Multidisciplinary consultation for patients with HPV-related invasive carcinoma or precancerous lesions]. , 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[5]  K. Sonawane,et al.  Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus–Associated Cancers , 2018, JAMA network open.

[6]  J. Piccirillo,et al.  Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma , 2018, JAMA otolaryngology-- head & neck surgery.

[7]  K. Stamatakis,et al.  Primary Cancer vs Competing Causes of Death in Survivors of Head and Neck Cancer , 2017, JAMA oncology.

[8]  S. J. Henley,et al.  Human Papillomavirus-Associated Cancers - United States, 2008-2012. , 2016, MMWR. Morbidity and mortality weekly report.

[9]  Julia H. Rowland,et al.  Anticipating the “Silver Tsunami”: Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[10]  Marta S. Patrucco,et al.  Prognostic impact of second primary tumors in head and neck cancer , 2016, European Archives of Oto-Rhino-Laryngology.

[11]  N. Uedo,et al.  Endoscopic surveillance of head and neck cancer in patients with esophageal squamous cell carcinoma , 2016, Endoscopy International Open.

[12]  M. Abramowitz,et al.  Head and neck second primary cancer rates in the human papillomavirus era: A population‐based analysis , 2016, Head & neck.

[13]  D. Takai,et al.  Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma , 2016, Expert review of anticancer therapy.

[14]  Yuh-Seog Jung,et al.  Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010) , 2015, PloS one.

[15]  Kan Zhai,et al.  HPV and lung cancer risk: a meta-analysis. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[16]  Jonn Wu,et al.  Incidence of second metachronous head and neck cancers: Population‐based outcomes over 25 years , 2014, The Laryngoscope.

[17]  M. Fukayama,et al.  Negative human papillomavirus status and excessive alcohol consumption are significant risk factors for second primary malignancies in Japanese patients with oropharyngeal carcinoma. , 2014, Japanese journal of clinical oncology.

[18]  Kevin C Oeffinger,et al.  Causes of death in long‐term survivors of head and neck cancer , 2014, Cancer.

[19]  L. Konge,et al.  Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review , 2014, British Journal of Cancer.

[20]  P. Dulguerov,et al.  [The indication of panendoscopy in the search for synchronous and metachronous head and neck cancer]. , 2013, Revue medicale suisse.

[21]  Q. Wei,et al.  Low risk of second primary malignancies among never smokers with human papillomavirus–associated index oropharyngeal cancers , 2013, Head & neck.

[22]  V. Biron,et al.  HPV Status and second primary tumours in Oropharyngeal Squamous Cell Carcinoma , 2013, Journal of Otolaryngology - Head & Neck Surgery.

[23]  S. Baxi,et al.  Synchronous cancers in patients with head and neck cancer , 2013, Cancer.

[24]  M. Scheurer,et al.  Anal Cancer Incidence and Survival: Comparing the Greater San-Francisco Bay Area to Other SEER Cancer Registries , 2013, PloS one.

[25]  A. Spira,et al.  Enriching the Molecular Definition of the Airway “Field of Cancerization:” Establishing New Paradigms for the Patient at Risk for Lung Cancer , 2012, Cancer Prevention Research.

[26]  H. Tsukuma,et al.  Incidence of metachronous second primary cancers in Osaka, Japan: Update of analyses using population‐based cancer registry data , 2012, Cancer science.

[27]  D. Jayalekshmi,et al.  Lung Cancer and Human Papilloma Viruses (HPVs): Examining the Molecular Evidence , 2012, Journal of oncology.

[28]  R. Shaw,et al.  Evaluation of Human Papilloma Virus Diagnostic Testing in Oropharyngeal Squamous Cell Carcinoma: Sensitivity, Specificity, and Prognostic Discrimination , 2011, Clinical Cancer Research.

[29]  G. Launoy,et al.  Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980-2005 and projection to 2010. , 2011, Oral oncology.

[30]  R. Hayes,et al.  Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  H. Brenner,et al.  Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. , 2010, The oncologist.

[32]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[33]  R. Gilbert,et al.  A rational approach to pulmonary screening in newly diagnosed head and neck cancer , 2005, Head & neck.

[34]  S. Franceschi,et al.  Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.

[35]  Stephen S. Hecht,et al.  Tobacco carcinogens, their biomarkers and tobacco-induced cancer , 2003, Nature Reviews Cancer.

[36]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[37]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[38]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.

[39]  T. Carey,et al.  An Algorithm to Evaluate Suspected Lung Metastases in Patients with HPV-Associated Oropharyngeal Cancer , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[40]  S. J. Henley,et al.  Five‐year relative survival for human papillomavirus‐associated cancer sites , 2018, Cancer.

[41]  L. Alemany,et al.  The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma. , 2017, Oral oncology.

[42]  K. Mak,et al.  Alcohol and cancer , 1986, Hepatology.

[43]  K. Syrjänen.  Condylomatous changes in neoplastic bronchial epithelium. Report of a case. , 1979, Respiration; international review of thoracic diseases.